Even when Americans have health insurance, they can have a hard time affording the drugs they’ve been prescribed.
Prescription costs and coverage hurdles are increasing, leading patients to act as their own payers in a fragmented system. Despite $5 billion annual investment in patient assistance programs, less ...
RAAP, the Rare Access Action Project, is a coalition of life sciences and patient stakeholders that explore creative policy ...